[vc_row][vc_column][vc_row_inner][vc_column_inner][vc_single_image image=»11752″ img_size=»full» alignment=»center» onclick=»link_image»][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row][vc_column width=»1/2″][vc_column_text]

Colaboradores Internacionales

Señalización Metabólica en la Insuficiencia Cardíaca

JA Hill & TG Gillette (UT Southwestern Medical Center, USA), S Davison & D Yellon (Hatter Cardiovascular Institute, UCL, London, UK), H Li (Wuham University, China), A San Martin (Emory University, USA), D Westenbrink (University of Groningen, The Netherlands).

Biomarcadores diferencias de género en la insuficiencia cardíaca

JA Hill & TG Gillette (UT Southwestern Medical Center, USA), D Westenbrink (University of Groningen, The Netherlands), Marta Sitges (Hospital Clinic, Barcelona, Spain).

Biología de células tumorales e inflamación

V Perez (Linus Pauling Institute, USA), C Salomon (University Queensland, Australia), C Rovira (University Lund, Sweden), Pascal Schneider (University Lausanne, Switzerland), Wael el Rifai (University Miami, USA), Chris Abneter (NCI, USA).

[/vc_column_text][/vc_column][vc_column width=»1/2″][vc_column_text]

Escenarios epigenómicos en cáncer gástrico

W El-Rifai (University Miami, USA), L Carvajal-Carmona (UC-Davis, USA), C Rabkin (NCI, USA).

Historia natural del cáncer digestivo

J Koshiol & A Hildesheim (NCI/USA), N Salama (Fred Hutchinson Cancer Research Center), M Levine (University of Maryland, USA), Christian Abnet & Constanza Camargo (NCI/NIH USA).

Nanomedicina y ciencia química para el diagnóstico y terapia de cáncer y enfermedades cardiovasculares

E Giralt (Institut of Biomedical Research Barcelona, Spain), F Albericio (University of Barcelona, Spain), J Samitier (Institute of Bioengineering of Catalonia, IBEC, Barcelona), GA Rivas, (University of Córdova, Argentina), LJ Cruz (University of Leiden, The Netherlands).

[/vc_column_text][/vc_column][/vc_row]